Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

90
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
90
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

93
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
93
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

5.5K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.5K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

70
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
70
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

83
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Optimal Sampling Strategies for Cefepime Model-Informed Precision Dosing.

Therapeutic drug monitoring·2026
Same author

The Visual Predictive Check and Real-World Data.

Clinical pharmacology and therapeutics·2026
Same author

Vancomycin target attainment improved following population pharmacokinetic model switch: a large-scale quasi-experimental study of precision dosing.

JAC-antimicrobial resistance·2026
Same author

Evaluation and Improvement of Specialized Vancomycin Pharmacokinetic Models for Pediatric Cardiovascular Intensive Care Unit and Pediatric Oncology Patients.

Clinical pharmacokinetics·2026
Same author

Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome.

Therapeutic drug monitoring·2026
Same author

Improved Prediction of Vancomycin Pharmacokinetics in Patients Receiving Continuous Renal Replacement Therapy Using a Novel Population Model Validated With Real-World Data.

Therapeutic drug monitoring·2026

Related Experiment Video

Updated: Jun 30, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.7K

Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing.

Jasmine H Hughes1, Janel Long-Boyle2,3, Ron J Keizer4

  • 1InsightRX, 548 Market St. #88083, San Francisco, CA, 94104, USA. jasmine@insight-rx.com.

Journal of Pharmacokinetics and Pharmacodynamics
|March 23, 2024
PubMed
Summary

Dose personalization for drugs like busulfan is key. Maximum a posteriori Bayesian (MAP) methods showed higher simulated target attainment than non-compartmental analysis (NCA) for optimizing drug doses.

Keywords:
Bayesian forecastingModel-informed precision dosingNon-compartmental analysisPharmacokinetics

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
09:58

Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS

Published on: April 18, 2018

9.1K

Related Experiment Videos

Last Updated: Jun 30, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.7K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
09:58

Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS

Published on: April 18, 2018

9.1K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Computational Biology and Bioinformatics
  • Clinical Pharmacology

Background:

  • Dose personalization enhances patient outcomes for drugs with narrow therapeutic indices and high inter-individual variability, such as busulfan.
  • Non-compartmental analysis (NCA) and maximum a posteriori Bayesian (MAP) approaches are standard methods for optimizing drug doses.
  • The differences in how these methods estimate patient-specific pharmacokinetic parameters and their impact on dose optimization are not fully understood.

Purpose of the Study:

  • To compare the performance of NCA and MAP methods in estimating pharmacokinetic parameters and achieving target drug exposure using busulfan as a model.
  • To evaluate the impact of different assumptions and data handling on area under the concentration-time curve (AUC) estimation.
  • To assess the simulated target attainment rates for dose adjustments using both NCA and MAP methods.

Main Methods:

  • Retrospective analysis of busulfan pharmacokinetic data from 246 patients.
  • Comparison of NCA (with and without peak extension) and MAP Bayesian estimation (using one-compartment Shukla and two-compartment McCune models).
  • Bland-Altman analysis for agreement on real-world data and simulation of dose adjustments for target attainment.

Main Results:

  • All methods demonstrated good agreement on real-world data (correlation coefficients 0.945-0.998).
  • Agreement between NCA and MAP was higher during the first dosing interval compared to subsequent intervals.
  • Simulated dose adjustments showed higher true target attainment with MAP (91-93%) versus NCA (63-66%), despite both estimating high attainment (>98%).

Conclusions:

  • While AUC estimates correlate well between NCA and MAP, MAP Bayesian estimation resulted in superior simulated target attainment.
  • Differences in AUC estimation are influenced by assumptions about infusion phase concentration curves and handling of time-dependent clearance.
  • Adjusting target exposure levels may be necessary when switching between estimation methods or altering parameters like infusion duration.